Skip to main content

Showing results for Alzheimer's disease

Researchers investigate connection between loss of motivation and Alzheimer’s disease progression

Researchers are studying why neuropsychiatric symptoms, such as apathy and irritability, appear in most Alzheimer’s disease patients before the onset of memory loss.

IU School of Medicine  |  Apr 25, 2022

Researchers discover new information about amyloid filaments in neurodegenerative diseases

Experts at Indiana University School of Medicine have helped identify that a common protein found in neurodegenerative diseases forms amyloid filaments in an age-dependent manner without a connection to disease.

IU School of Medicine  |  Mar 28, 2022

New study shows pathological differences in inherited versus sporadic Alzheimer's disease

Indiana University School of Medicine researchers are making new discoveries about the pathological changes in people who have inherited Alzheimer’s disease versus developing the disease sporadically. These findings could lead to new ways of preventing and treating the disease.

Christina Griffiths  |  Jan 18, 2022

Alzheimer’s disease research programs at IU School of Medicine collaborate on disease models, drug discovery of gene

Investigators from two of Indiana University School of Medicine’s largest funded research programs are collaborating on a study investigating the biology behind a gene associated with Alzheimer’s disease, with the hopes of developing a drug to treat the disease.

IU School of Medicine  |  Nov 09, 2021

Researchers investigate role of gene associated with Alzheimer’s disease in brain’s immune cells

When immune cells move throughout the brain, they act as the first line of defense against viruses, toxic materials and damaged neurons, rushing over to clear out them. Researchers at Indiana University School of Medicine have been investigating how these immune cells in the brain—microglia—relate to a gene mutation recently found in Alzheimer’s disease patients. 

IU School of Medicine  |  Nov 03, 2021

IU researcher member of expert panel on Alzheimer's disease drug

When the Food and Drug Administration approved the use of the drug aducanumab to treat Alzheimer’s disease in early June, leaders in neurodegeneration research quickly created an expert panel to issue guidance to physicians on how to best administer the drug.

IU School of Medicine  |  Sep 08, 2021

IU School of Medicine's Indiana Alzheimer’s Disease Research Center awarded additional $15 million in funding from the National Institute on Aging

Indiana University School of Medicine is pleased to announce its Indiana Alzheimer’s Disease Research Center (IADRC) grant has been renewed for another five years.

IU School of Medicine  |  Sep 07, 2021

IU School of Medicine study shows link between head injury and Alzheimer’s disease

New research from Indiana University School of Medicine shows that the presence of neurodegenerative proteins is associated with common head injury among the general population.

IU School of Medicine  |  Aug 24, 2021

Researchers receive multi-million dollar grant to study early detection of Alzheimer’s disease

A new $11.2 million grant coordinated by the Indiana University School of Medicine from the National Institute on Aging (NIA) will support an international collaboration on multiethnic genomic analysis and advanced brain imaging and other biomarkers for early detection of Alzheimer’s disease.

IU School of Medicine  |  Aug 18, 2021

New study from IU helps researchers understand spreading patterns of Alzheimer's

As new approaches for Alzheimer’s disease diagnosis and treatment emerge, it’s more important than ever to understand the ties between disease pathology, brain connections and genetics.

IU School of Medicine  |  Jul 27, 2021